News: GMV G Medical Innovations Holdings Ltd Files To Withdraw U.S. IPO Plans, page-38

First 38 Last

Share
Profile

Follow
Upthefog

1,709 Posts.

614

22/08/19

15:56

Post #: 40100749
Share

Originally posted by Galilee13 ↑

Here's my 2 cents

Agree with @Glyco and @harlen. Less dilution the better. And yes plenty of red flags along the way. Everyone knew these and were discussed along the way, but investors placed there bets accordingly.

I don't think the market was expecting the Nasdaq ipo to go ahead in the short term. With a sp half that of the underwriten price. That tells you everything.

Problem is it's another knock to management credibility and it's ability to execute.

So where to from here? The TH should address the companies funding position going forward. At what point does Yacov take this private and re ipo in a few years time? Does yacov have a white knight that's going to buy in at a premium? Does he tap the controlled equity facility? Does he just keep funding the company month to month until its cash flow positive? Does he buy back all the convertible notes and clean up the balance sheet? One would think he has the funds to do all these.

I have always said "why now" when the company has made a particular announcement. When the company decided to list on the Nasdaq in June, both yacov and Brendan buy more stock as I'm assuming it's was finally about to all fall into place. HC Wainwright underwrites and organised a roadshow. But then anything and everything went wrong. So why announce canceling the Nasdaq ipo now?

As I've said before. GMV has 2 products with approvals in CE, FDA and TGA. An approved factory. A management team that's "been there, done that" with 100% regulatory approval track record. All that's been lacking is execution.

Is a Nasdaq IPO really going change much in the short term? It's defiantly not going to effect sales efforts in the UK or the regulatory process in China.

Keep in mind the initial Nasdaq ipo announcement did not much for the share price. I personally hoped it resulted in a valuation re rate based on BEAT and IRTC. But never believed it's would effect the underlying business.

A TH until Monday suggest they have something else in the works. No need for that much time.

Expand

G13- a sound & well structured post.

What in your opinion are the reasons for failing to execute anything of substance? If they have the people with the track record - is it the service & product that has simply failed to excite anyone? Surely in those countries not dependant on regulatory approval at least one contract of substance should have been locked away? Do you think maybe they in turn are all waiting for the Chinese approval to come through??

To my mind we are well beyond a green fields start up operation & more worryingly maybe the product / service is no good - notwithstanding the vast potential of remote monitoring.

Last edited by Upthefog: 22/08/19

GMV Price at posting: 12.0¢ Sentiment: None Disclosure: Held
9 Upvote

0 Great analysis

Reply

Top Stories

NAM

Olam Agri raises Namoi takeover offer to 75 cents a share and receives shareholder backing

MKG

Mako sniffs gold at 170 g/t at Cote d’Ivoire's Napié play

MM8

Medallion Metals kicking off 15,000m drill run at Ravensthorpe gold play

ASN

Utah authorities sign off on Anson's lithium extraction plans at Green River

AZY

Antipa divests its Citadel interest to JV partner Rio for A$17M, refocuses on Minyari Dome

Week 37 Wrap: HotCopper likes Cuban oil; markets shrug debate off for Putin; firebrand quant says social media a market threat

MLS

Metals Australia kicking off plant study at Lac Carheil; Canadian tariff tailwind potential

Dale Gillham's weekly wrap: US fracking support boosts outlook for Australian gas stocks

VUL

Vulcan appoints investment bank and M&A veteran to board

ENV

Enova Mining unveils "high-grade" REE drill hits at Coda North, Brazil

There are more pages in this discussion • 25 more messages in this thread...

First 38 Last

Add GMV (ASX) to my watchlist

News: GMV G Medical Innovations Holdings Ltd Files To Withdraw U.S. IPO Plans, page-38

Top Stories

Olam Agri raises Namoi takeover offer to 75 cents a share and receives shareholder backing

Mako sniffs gold at 170 g/t at Cote d’Ivoire's Napié play

Medallion Metals kicking off 15,000m drill run at Ravensthorpe gold play

Utah authorities sign off on Anson's lithium extraction plans at Green River

Antipa divests its Citadel interest to JV partner Rio for A$17M, refocuses on Minyari Dome

Week 37 Wrap: HotCopper likes Cuban oil; markets shrug debate off for Putin; firebrand quant says social media a market threat

Metals Australia kicking off plant study at Lac Carheil; Canadian tariff tailwind potential

Dale Gillham's weekly wrap: US fracking support boosts outlook for Australian gas stocks

Vulcan appoints investment bank and M&A veteran to board

Enova Mining unveils "high-grade" REE drill hits at Coda North, Brazil

Featured News